Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington's Disease: Preclinical Evidence with the p75NTR Ligand LM11A-31.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: February 02, 2021
TSPO-PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington's disease: preclinical evidence with the p75NTR ligand LM11A-31.
Journal: Human molecular genetics
Published: February 20, 2018
Showing 1-2 of 2
Last Updated: 09/26/2026